Tuberculosis Diagnostics Market Trends, Price, Demand and Forecasts To 2024

Hexa Reports
Market Research Reports and Insightful Company Profiles
Global Tuberculosis Diagnostics Market Size, Share,
Strategies, Global Insights, Analysis and Forecasts, 2016 To
2024
The global tuberculosis diagnostics market is expected to reach USD 3.1 billion by 2024, according to a
new report by Grand View Research, Inc. Advent of advanced diagnostic methods such as Interferongamma Release Assay (IGRA), serological methods, and nucleic acid testing have resulted in the high
usage rate of diagnostics. Moreover, Point of Care (POC) technologies such as antigen assays are also
promoting the diagnosis rate of TB.
These advanced methods including POC diagnostics are affordable, accurate, simple, and yield quick
results. Furthermore, the rising burden of TB is the primary factor responsible for the lucrative market
growth. As per the World Health Organization, the global estimates of patients afflicted with TB were
around 9.6 million in 2014. This high prevalence rate has led the government, healthcare organizations,
research institutes, and market players to initiate endeavors directed toward containing the incidence of
this infectious disease.
The increasing screening rate in the high burden regions, affordability of diagnostics, advanced
methodologies, faster clinical decisions, and reduction in mortality rate are the focal areas of
development. Improved preventive and curative diagnosis rates are the end results of these initiatives.
This has led to a subsequent upsurge in the demand for diagnostic tests and the TB diagnostics market.
Browse Detail Report With [email protected] http://www.hexareports.com/report/tuberculosis-diagnosticsmarket/details
Hexa Reports
Market Research Reports and Insightful Company Profiles
Further key findings from the study suggest:
Based on tests type, the tuberculosis diagnostics market is segmented into radiographic methods,
diagnostic laboratory methods, nucleic acid testing, phage assay, detection of latent infection, cytokine
detection assay, and detection of drug resistance.
Diagnostic laboratory tests dominated the test type segment with 38.0% market share in 2015 as they
are cost efficient and easy-to-perform. Diagnostic laboratory tests include smear microscopy and
culture-based tests. The high burden regions rely on these methodologies due to their financial and
technical incapability to incorporate advanced technologies thus contributing to the growth of the
diagnostic laboratory tests segment.
However, compromised accuracy and the longer processing time are the limiting factor for the
diagnostics. Hence, healthcare agencies are striving to implement advanced techniques in the
developing regions.
As a result, nucleic acid tests segment and the latent infection detection segment, which includes skin
tests and IGRA, are likely to exhibit a profitable growth rate. These methods overcome the
aforementioned limitations thus improving affordability, processing time and accuracy of the diagnostic
method.
Drug resistance in tuberculosis is one of the primary concerns for healthcare professionals as improper
treatment due to wrong drug regimen and incorrect dosage forms lead to the development of drug
resistance in TB patients undergoing treatment. Hence, the drug resistance detection segment is also
anticipated to witness lucrative growth.
Asia Pacific owing to its huge population base and high burden of TB dominated the global TB
diagnostics market in 2015. As per the WHO, countries such as India, China, Afghanistan, and Indonesia
are priority regions for control of this communicable disease.
The players in the TB testing market include Thermo Fisher Scientific, Inc., Hologic Corporation, Abbott
Laboratories, Alere, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, bioMerieux SA,
Sanofi, Cepheid, Hain Lifescience GmbH, and QIAGEN.
New product launches, collaboration, mergers & acquisitions, and regional expansion are the key
strategic initiatives undertaken by these industry players
For instance, in July 2016, bioMerieux launched a novel CE marked database and reagents kit VITEK MS
for the identification of TB. This new product launch is anticipated to help the company increase its
market share.
Hexa Reports
Market Research Reports and Insightful Company Profiles
Request A Sample copy of This Report @ http://www.hexareports.com/sample/159480
Table Of Content
Chapter 1 Research Methodology
1.1 Research Methodology
1.2 Research Scope & Assumptions
1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Market Summary
Chapter 4 Market Variables, Trends & Scope
4.1 Market Segmentation & Scope
4.2 Market Driver Analysis
4.3 Market Restraint Analysis
4.4 Penetration & Growth Prospect Mapping
4.5 SWOT Analysis, By Factor
4.5.1 Political
4.5.2 Economic
4.5.3 Technology
Chapter 5 Market Categorization 1: Test Types Estimates & Trend Analysis
5.1 Test Types Movement Analysis & Market Share, 2015 & 2024
5.2 Market Size & Forecasts and Trend Analyses, 2013 to 2024 for the following products:
5.2.1 Radiographic method
5.2.2 Diagnostic Laboratory methods
5.2.2.1 Smear microscopy
5.2.2.2 Culture-based test
5.2.3 Nucleic acid testing
5.2.4 Phage assay
5.2.5 Detection of latent infection
5.2.6 Cytokine detection assay
5.2.7 Detection of drug resistance
5.2.8 Other methods
Chapter 6 Market Categorization 2: Regional Estimates & Trend Analysis
6.1 Regional Movement Analysis & Market Share, 2015 & 2024
6.2 Market Size & Forecasts and Trend Analyses, 2013 to 2024 for the following regions:
6.2.1 North America
6.2.1.1 U.S.
6.2.1.2 Canada
6.2.2 Europe
6.2.2.1 UK
6.2.2.2 Russian Fedration
Hexa Reports
Market Research Reports and Insightful Company Profiles
6.2.3 Asia Pacific
6.2.3.1 China
6.2.3.2 India
6.2.4 Latin America
6.2.4.1 Brazil
6.2.4.2 Mexico
6.2.5 MEA
6.2.5.1 South Africa
Browse Full Report @ http://www.hexareports.com/report/tuberculosis-diagnostics-market/details
About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe. We offer comprehensive
business intelligence in the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Contact Information:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: [email protected]
Our Website: http://www.hexareports.com/
Visit Our Blogs: http://hexareports.blogspot.in

The global tuberculosis diagnostics market is expected to reach USD 3.1 billion by 2024, according to a new report by Grand View Research, Inc. Advent of advanced diagnostic methods such as Interferon-gamma Release Assay (IGRA), serological methods, and nucleic acid testing have resulted in the high usage rate of diagnostics